Appleton Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$271K Buy
3,875
+257
+7% +$18.2K 0.94% 22
2023
Q2
$250K Buy
+3,618
New +$257K 0.35% 31
2023
Q1
Sell
-2,925
Closed -$273K 34
2022
Q4
$273K Sell
2,925
-186
-6% -$17.9K 0.4% 31
2022
Q3
$297K Buy
+3,111
New +$308K 0.85% 19
2022
Q2
Sell
-4,469
Closed -$452K 31
2022
Q1
$452K Sell
4,469
-36
-0.8% -$3.78K 0.63% 17
2021
Q4
$465K Sell
4,505
-16
-0.4% -$1.48K 0.47% 22
2021
Q3
$384K Sell
4,521
-132
-3% -$11.1K 0.33% 24
2021
Q2
$388K Buy
4,653
+11
+0.2% +$901 0.3% 30
2021
Q1
$349K Buy
+4,642
New +$338K 0.46% 27

Other funds holding CVS

Appleton Group's CVS Position: Q3 2023 in Review

Appleton Group increased its CVS Health (CVS) stake by 7.1% in Q3 2023, buying an estimated $18.2K and bringing the position to 3,875 shares worth $271K. The position accounts for 0.94% of the portfolio, ranked #22.

Appleton Group first reported a position in CVS in Q1 2021 and has held it in 9 quarters since. The position peaked at $465K in Q4 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Appleton Group held 3,875 shares of CVS Health worth $271K as of Q3 2023.
  • Appleton Group bought 257 CVS Health shares in Q3 2023, an estimated $18.2K.
  • CVS Health made up 0.94% of Appleton Group's portfolio in Q3 2023, its #22 holding.
  • Appleton Group first reported a position in CVS Health in Q1 2021 and has held it in 9 quarters since.
  • Appleton Group's CVS Health position peaked at $465K in Q4 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Appleton Group's 13F filing for Q3 2023, filed 8 Nov 2023.